denotes Educational Track
1 Antimicrobial Resistance; 2 Collaboration; 3 Disinfection Sterilization; 4 Emergency Room Preparedness; 5 IC Program and Business;
6 International; 7 Leadership; 8 New Infection Preventionist; 9 Skill Development; 10 Special Populations/Special Settings; 11 Surveillance
Concurrent Session
4:00 PM - 5:00 PM
4:00 PM - 5:00 PM
 Preventing Infections Through Informatics
1/6
Clostridium difficile in the United Kingdom
Linda Goss MSN, RN-BC, CIC, COHN-S
Director, Infection Prevention and Vascular Access
Martin Kiernan, RN, MPH, President
University of Louisville Hospital, Louisville, KY
Infection Prevention Society and Nurse Consultant, Southport
and Ormskirk Hospital NHS Trust, Southport, United Kingdom
Well designed information infrastructures can facilitate infection
prevention efforts. Mandatory reporting demands continue to
The presenter will examine the trend in C. difficile in the UK
stress information technology systems and the budgets for
over the past nine years as well as factors that contributed to rate
their design. This program aims to clarify informatics and
fluctuation.
its implications in infection prevention and to identify the
Session is sponsored by an unrestricted education
tools necessary for evaluation and selection of an electronic
grant from BD. The speaker is not sponsored.
surveillance system.
4:00 PM - 5:00 PM
4:00 PM - 5:00 PM
8/11
 Getting to Zero Ventilator-Associated
Stopping Upper Respiratory Infections and Flu
Pneumonia: It’s About Teamwork
in the Family: The Stuffy Trial
Shawn Mueller, MSN, RN, CIC
Elaine Larson, PhD, FAAN, RN, CIC
Epidemiologist
Associate Dean
BryanLGH Medical Center, Lincoln, NE
Columbia University School of Nursing, New York, NY
This session will present results of a randomized clinical trial
The presenter will discuss one hospital’s journey to achieving
using three interventions (culturally-relevant education, alcohol
zero ventilator-associated pneumonias (VAP). Modifiable and
hand sanitizers, masks) to reduce upper respiratory infections
non-modifiable risk factors along with nursing barriers to VAP
(URIs) and influenza transmission in households.
prevention will be reviewed. Evidence-based practice, the
exploration of innovative interventions as well as the differing
4:00 PM - 5:00 PM
perspectives of multiple stakeholders will be examined.
1/10
 The Prevention of MDRO Transmission in
4:00 PM - 5:00 PM
Behavioral Health Settings
1/10
Managing MRSA in Long-Term Care Facilities
Melanie B. Koch, BSN, RN
Deborah Burdsall, RN, MSN, CIC
Infection Control Practitioner
Infection Control Coordinator
Parkview Health, Fort Wayne, IN
Lutheran Home Services, Palatine, IL
Traditional contact precautions create barriers to behavioral
An effective Long-Term Care (LTC) infection prevention
health (BH) treatment. An algorithm for Modified Contact
and control program is comprised of many components and
Precautions (MCP) was developed to assess the MDRO patient
interventions that can reduce MRSA risk to residents, healthcare
clinically and behaviorally. This modified contact precaution risk
providers, staff, and visitors. The presenter will discuss strategies
assessment tool can be applied to a variety of healthcare settings
and tools that can be used for MRSA management in the long-
where group activities are an integral component of care. The
term care facility. The successful management of MRSA in LTC
presenter will provide tools to implement MCP.
will ensure the best possible outcomes for all residents, and may
prevent the negative impact that MRSA infections can have on
4:00 PM - 5:00 PM
quality of life for all residents.
The Role of Biofilm in Healthcare-Associated
Session is sponsored by an unrestricted education Infections
grant from BD. The speaker is not sponsored.
Marcia Ryder, PhD, MS, RN
Medical Biofilm Research & Consulting, Los Angeles, CA
The presenter will examine the role of microbial biofilms in
healthcare-associated infections. New scientific discoveries in
medical biofilm research will be presented along with exemplar
strategies to reduce the risk of biofilm infections.
Session is sponsored by an unrestricted education
grant from BD. The speaker is not sponsored.
APIC 2009, Ft. Lauderdale, FL, June 7-11 13
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32